NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Agreed 100%. None of the in licensing gimmick is going to add any value over the next couple of years. Roswell news is a prime example. Markets didn’t care and will not care. They have no cash to run any trials themselves or scale their commercial operations. However, that could change with a big pharma partnership, both with upfront cash injection as well as the credibility + marketing opportunity that will provide.